#Micro Guide Catheters

[bommagoni]

Micro Guide Catheters Market Size, Share, Growth, Forecast

[soumyafwr]

Micro Guide Catheters Market Size, Analysis and Forecast 2031

[researchreport24]

Navigating the Labyrinth: An In-Depth Look at the Micro Guide Catheters Market

The medical device landscape is constantly evolving, driven by the persistent pursuit of less invasive, more precise, and ultimately, safer patient care. In this dynamic environment, micro guide catheters have emerged as indispensable tools, revolutionizing interventional procedures across various medical disciplines. This blog delves into the intricate world of the micro guide catheters market, offering a comprehensive overview of its current state, key drivers, emerging trends, and the promising future it holds.

Market at a Glance: A Picture of Growth

The Micro Guide Catheters Market is expected to register a CAGR of 6.5% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031. This upward trajectory is primarily fueled by the escalating global prevalence of chronic diseases, particularly cardiovascular and neurovascular disorders, and the increasing demand for minimally invasive surgical procedures.

Drivers of Expansion: Why the Market is Thriving

Several critical factors are acting as catalysts for the micro guide catheters market's expansion:

Rising Burden of Chronic Diseases: Cardiovascular diseases (CVDs) and neurovascular disorders remain leading causes of morbidity and mortality worldwide. Conditions like coronary artery disease, peripheral arterial disease, strokes, and aneurysms necessitate highly precise interventions, where micro guide catheters play a pivotal role in delivering therapeutic devices. The aging global population, highly susceptible to these age-related conditions, further amplifies this demand.

Growing Preference for Minimally Invasive Procedures: Patients and healthcare providers alike are increasingly opting for minimally invasive surgeries due to their numerous benefits. These include reduced recovery times, less post-operative pain, smaller incisions, and a lower risk of complications compared to traditional open surgeries. Micro guide catheters are integral to these procedures, enabling clinicians to navigate complex anatomical structures with enhanced precision.

Technological Advancements and Innovation: Continuous innovation in catheter design and materials is a key market driver. Manufacturers are focused on developing micro guide catheters with improved maneuverability, flexibility, pushability, torqueability, and safety profiles. This includes the integration of advanced materials like nitinol and hydrophilic coatings to reduce friction and enhance navigation through tortuous vessels. The emergence of steerable and dual-llumen microcatheters further expands their utility in complex cases.

Increasing Healthcare Expenditure and Infrastructure Development: Globally, governments and private entities are investing more in healthcare infrastructure and adopting advanced medical technologies. This increased investment facilitates the adoption of sophisticated tools like micro guide catheters, particularly in emerging economies where healthcare access and quality are improving.

Get Free Sample For Micro Guide Catheters Market - https://www.theinsightpartners.com/sample/TIPMD00002079 

Challenges and Opportunities: Navigating the Future

While the market outlook is overwhelmingly positive, certain challenges need to be addressed. The high manufacturing costs associated with the complex design and advanced technology of micro guide catheters can limit their affordability, especially in developing regions. Additionally, competition from traditional diagnostic and therapeutic methods remains a factor.

However, these challenges are overshadowed by significant opportunities:

Integration of Advanced Technologies: The future of micro guide catheters lies in the integration of cutting-edge technologies. This includes nanotechnology for further miniaturization and precision, and "smart guidewires" equipped with sensors for real-time location, pressure, and temperature data, providing unprecedented levels of guidance and safety during procedures.

Expansion into Emerging Markets: As healthcare infrastructure and disposable incomes continue to rise in emerging economies, there's immense potential for market expansion in these regions.

Focus on Biocompatibility and Patient Safety: Ongoing advancements in biocompatible materials will further enhance patient safety, reducing the risk of adverse reactions and complications.

Conclusion: A Vital Tool for Precision Medicine

The micro guide catheters market is a testament to the ongoing evolution of interventional medicine. As chronic diseases continue to pose significant health challenges and the demand for less invasive procedures intensifies, these tiny yet powerful devices will remain at the forefront of medical innovation. With continuous technological advancements and a growing global focus on enhancing patient outcomes, the micro guide catheters market is poised for sustained growth, offering significant opportunities for both established players and new entrants to shape the future of precision medicine. 

[thoratketan]

Global Neurovascular Devices Market report: Market Analysis And Strategic Insights

The global Neurovascular Devices Market, valued at USD 3.35 billion in 2023, is poised for robust growth, with projections indicating it will reach USD 6.60 billion by 2032. This represents a compound annual growth rate (CAGR) of 7.85% over the forecast period from 2024 to 2032. The increasing prevalence of neurovascular diseases, advancements in medical technology, and the rising demand for minimally invasive procedures are among the key factors driving the growth of the neurovascular devices market.

Get Free Sample Report on Neurovascular Devices Market

Understanding Neurovascular Devices

Neurovascular devices are specialized medical instruments designed to treat various neurovascular diseases and conditions affecting the blood vessels in the brain and spinal cord. These devices are critical in the management of disorders such as stroke, aneurysms, arteriovenous malformations (AVMs), and other conditions that compromise the vascular health of the brain. Neurovascular devices are used in both diagnostic and therapeutic procedures, including procedures like embolization, thrombectomy, and aneurysm coiling.

The growing focus on improving healthcare outcomes, particularly in the field of neurology and neurovascular treatments, is expected to drive the demand for advanced neurovascular devices globally. As the technology continues to evolve, these devices are becoming increasingly effective, improving patient outcomes and reducing recovery times associated with neurovascular procedures.

Key Market Drivers

1. Rising Prevalence of Neurovascular Diseases

One of the primary factors driving the growth of the neurovascular devices market is the rising incidence of neurovascular diseases, including stroke, brain aneurysms, and arteriovenous malformations. According to the World Health Organization (WHO), stroke is one of the leading causes of death and disability globally. As the global population ages and lifestyle-related factors such as high blood pressure, smoking, and diabetes increase, the number of individuals affected by these conditions is expected to rise, creating a greater demand for neurovascular devices.

Stroke, in particular, has seen increasing incidence rates, especially in aging populations. This creates an urgent need for improved diagnostic and therapeutic options. The rise in the number of individuals suffering from these conditions will drive the demand for devices such as stents, catheters, coils, and thrombectomy devices that are used to treat stroke and other neurovascular disorders.

2. Advancements in Medical Technology

Technological advancements in neurovascular devices are playing a key role in expanding the market. Newer devices with improved functionality and greater precision are enhancing the efficacy of procedures such as thrombectomy and aneurysm treatment. For instance, the introduction of neurovascular stents and embolization coils has greatly advanced the treatment options for stroke and aneurysms, offering better outcomes with reduced risks for patients.

Minimally invasive techniques, such as endovascular procedures, are becoming more common in treating neurovascular conditions. These techniques involve the use of devices such as catheters and micro-catheters, which are inserted through small incisions and guided to the affected areas of the brain. The use of these minimally invasive methods not only reduces recovery time but also improves the overall success rate of the procedures. As technology continues to improve, these procedures are expected to become more effective and widely adopted, further propelling the growth of the neurovascular devices market.

3. Increasing Focus on Minimally Invasive Procedures

Minimally invasive neurovascular procedures are becoming the preferred option for treating a variety of conditions. These procedures, which involve the use of catheters and other small devices to treat neurovascular diseases, are associated with reduced recovery times, lower infection rates, and less overall trauma for patients. As patients seek alternatives to traditional, more invasive surgeries, the demand for minimally invasive treatments using neurovascular devices is growing.

The shift toward minimally invasive techniques is being supported by the ongoing development of advanced neurovascular devices that are designed for greater precision, control, and safety. This trend is expected to continue, with hospitals and healthcare facilities increasingly adopting these devices to offer patients better outcomes and reduced procedure-related risks.

4. Government Initiatives and Funding

Governments and healthcare organizations are recognizing the growing burden of neurovascular diseases and are implementing various initiatives to address the issue. In many countries, the government is increasing its focus on improving healthcare infrastructure and funding research into more effective treatments for stroke, aneurysms, and other neurovascular conditions. This increased funding for research and development is helping fuel innovation in the neurovascular device market.

Additionally, many healthcare systems are investing in specialized neurovascular centers equipped with advanced technology to improve diagnostic and treatment capabilities. As public and private investments in neurovascular care grow, the demand for state-of-the-art neurovascular devices is also expected to rise.

5. Aging Population and Increasing Life Expectancy

The aging global population is another major driver of the neurovascular devices market. As people live longer, the incidence of age-related diseases, including neurovascular disorders, is increasing. The elderly population is particularly susceptible to conditions like stroke and brain aneurysms, which can significantly affect their quality of life.

With the global population continuing to age, the demand for effective treatment options to address these conditions will increase. Neurovascular devices, which play a key role in treating stroke and other vascular issues in the brain, are expected to be in higher demand to meet the needs of this growing patient demographic.

Market Segmentation

The global neurovascular devices market is segmented based on type, application, end-user, and region.

By Type: The market is segmented into aneurysm coiling & embolization devices, neurovascular stents, thrombectomy devices, support devices, and others. Aneurysm coiling & embolization devices are expected to dominate the market due to their critical role in treating brain aneurysms and stroke prevention.

By Application: The neurovascular devices market serves a wide range of applications, including stroke, aneurysm treatment, and arteriovenous malformations (AVMs). Stroke management, particularly ischemic stroke, is expected to be the largest segment, driven by the growing prevalence of stroke globally.

By End-User: Hospitals, specialty clinics, and ambulatory surgical centers are the key end-users of neurovascular devices. Hospitals are the largest end-user segment, as they offer comprehensive neurovascular care and have the necessary infrastructure for advanced procedures.

Make Enquiry about Neurovascular Devices Market

Key Players and Their Neurovascular Device Offerings

Conclusion

The global neurovascular devices market is poised for substantial growth, with a projected increase from USD 3.35 billion in 2023 to USD 6.60 billion by 2032. The increasing prevalence of neurovascular diseases, advancements in medical technologies, and the growing demand for minimally invasive procedures are key factors driving the market's expansion. As the healthcare industry continues to prioritize effective treatments for stroke, aneurysms, and other neurovascular conditions, the demand for advanced neurovascular devices will continue to rise, paving the way for a future of improved patient outcomes and more effective treatments.

About US:

SNS Insider Is One Of The Leading Market Research And Consulting Agencies That Dominates The Market Research Industry Globally. Our Company's Aim Is To Give Clients The Knowledge They Require In Order To Function In Changing Circumstances. In Order To Give You Current, Accurate Market Data, Consumer Insights, And Opinions So That You Can Make Decisions With Confidence, We Employ A Variety Of Techniques, Including Surveys, Video Talks, And Focus Groups Around The World.

Contact Us:

Jagney Dave - Vice President Of Client Engagement

Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)

[healthcare-updates-with-sns]

Assisted Reproductive Technology (ART) Market: Market Forecast and Market Trends 2024-2032

The Assisted Reproductive Technology (ART) Market was valued at USD 28.33 billion in 2023 and is projected to reach USD 55.09 billion by 2032, growing at a CAGR of 7.68%. This growth is driven by increasing infertility rates, advancements in ART procedures, and greater societal acceptance of fertility treatments.

Regional Analysis

Europe led the ART market in 2023, accounting for a significant revenue share. This dominance is attributed to rising infertility rates, heightened awareness of fertility treatments, technological advancements, and supportive government initiatives. North America is also anticipated to experience significant growth due to favorable patient outcomes and increasing adoption of ART services.

Get Free Sample Report @ https://www.snsinsider.com/sample-request/3447

Market Segmentation

By Type:

In-vitro fertilization (IVF)

Artificial Insemination

By End-use:

Fertility Clinics & other settings

Hospitals and others

Key Players

Cosmos Biomedical Ltd. - Sperm Processing Kits, Embryo Transfer Catheters

Microm U.K. Ltd. - Embryo Culture Media, IVF Laboratory Equipment

CooperSurgical, Inc. - Gavi IVF System, EmbryoScope, Fertility Preservation Devices

FUJIFILM Irvine Scientific - ART Culture Media, Oocyte Handling Products

Cryolab Ltd. - Cryopreservation Systems, Cryogenic Vials

Vitrolife AB - Embryo Culture Media, IVF Consumables

European Sperm Bank - Donor Sperm, Sperm Cryopreservation Kits

Bloom IVF Centre - IVF Services, Embryo Culture Media

Merck KGaA - Oocyte Cryopreservation Products, IVF Media

Ferring B.V. - Ovarian Stimulation Products, ART Drugs

Hamilton Thorne, Inc. - CASA (Computer Assisted Semen Analysis) Systems, Micromanipulation Systems

Nikon Corporation - Inverted Microscopes for IVF, Imaging Systems

Nidacon International AB - Sperm Processing and Freezing Products, IVF Consumables

Laboratoire CCD - Sperm Preparation Media, IVF Kits

Esco Micro Pte. Ltd. - IVF Incubators, Sperm Sorting Systems

Key Points

Technological advancements, such as genetic screening and improved IVF culture media, have enhanced ART success rates.

The high cost of ART treatments and limited insurance coverage remain significant barriers to market growth.

Government support and healthcare reforms are expanding access to fertility services.

The trend of fertility preservation, including egg freezing, is broadening the market base.

Future Scope

The ART market is poised for substantial growth, driven by continuous technological innovations and increasing global acceptance of fertility treatments. Emerging trends, such as fertility preservation and medical tourism, present new opportunities for market expansion. However, addressing cost barriers and improving insurance coverage will be crucial to making ART services more accessible to a broader population.

Conclusion

The Assisted Reproductive Technology market is experiencing significant growth, fueled by technological advancements and rising demand for fertility treatments. While challenges like high costs and limited insurance coverage persist, ongoing government initiatives and societal acceptance are expected to drive further market expansion in the coming years.

Contact Us: Jagney Dave - Vice President of Client Engagement Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)

Other Related Reports:

Fertility Services Market

Medical Power Supply Market

Post Traumatic Stress Disorder Treatment Market

MRI Guided Neurosurgical Ablation Market

[pleasantkingcomputer]

SD-Steel: 0.1mm Stainless Steel Capillary Tube


At SD-Steel, we are dedicated to providing high-quality stainless steel products that meet the most stringent industry standards. Our 0.1mm Stainless Steel Capillary Tube is a testament to our commitment to excellence and precision.

Product Description

Our 0.1mm Stainless Steel Capillary Tube is designed for applications requiring precise dimensions and exceptional durability. It is ideal for use in medical devices, aerospace components, and precision engineering projects where reliability and accuracy are paramount.

Material

The capillary tube is made from high-grade stainless steel, ensuring corrosion resistance and longevity. The material composition adheres to international standards, making it suitable for a wide range of applications.

Specifications

| Parameter | Details |

|---------------|-------------|

| Material | Stainless Steel |

| Outer Diameter (OD) | 0.1mm |

| Inner Diameter (ID) | Customizable |

| Length | Up to 6 meters |

| Tolerance | ±0.005mm |

Dimensions

The 0.1mm Stainless Steel Capillary Tube can be customized to specific lengths and inner diameters as per customer requirements. This flexibility allows for seamless integration into various systems and devices.

Usage Scenarios

Medical Devices: Used in catheters, syringes, and other medical instruments where precision and sterility are critical.

Aerospace Industry: Essential for fuel lines, hydraulic systems, and other components requiring high strength and corrosion resistance.

Precision Engineering: Ideal for sensors, actuators, and other micro-engineering applications.

Company Strengths

SD-Steel boasts over two decades of experience in the steel industry. Our state-of-the-art manufacturing facilities and rigorous quality control processes ensure that every product meets or exceeds customer expectations. We pride ourselves on our commitment to innovation and customer satisfaction.

FAQs

Q: What is the minimum order quantity for the 0.1mm Stainless Steel Capillary Tube?

A: The minimum order quantity is typically 100 meters, but we can accommodate smaller orders upon request.

Q: Can the capillary tube be customized to different lengths and inner diameters?

A: Yes, we offer customization services to meet your specific project requirements. Please contact us for more details.

Q: How do I place an order?

A: You can place an order by contacting us at +65 83016969. Our sales team will guide you through the process and provide any necessary assistance.

For further inquiries or to place an order, please contact us at +65 83016969. We look forward to serving you with the highest quality stainless steel products.

加飞机@yuantou2048

Stainless Steel Coil

Stainless Steel Strip

[aliyacosk2]

https://www.databridgemarketresearch.com/ko/reports/global-micro-guide-catheters-market

[australianconcept22]

Intracytoplasmic Sperm Injection (ICSI): A Detailed Overview

Intracytoplasmic Sperm Injection (ICSI) is a specialized form of assisted reproductive technology (ART) that has revolutionized the treatment of male infertility. This innovative procedure allows for the direct injection of a single sperm into an egg, significantly increasing the chances of fertilization, particularly in cases where traditional fertilization methods may not be effective. Since its introduction in the early 1990s, ICSI has become a cornerstone of in vitro fertilization (IVF) and has helped millions of couples achieve their dream of parenthood. This article explores the ICSI process, its benefits, potential risks, and the circumstances under which it is typically used.  Australian concept karachi

Understanding ICSI

ICSI is often used in conjunction with IVF, where eggs are retrieved from a woman's ovaries and fertilized outside her body. The primary difference between traditional IVF and ICSI lies in how the sperm is introduced to the egg. In conventional IVF, sperm and eggs are combined in a petri dish, allowing fertilization to occur naturally. However, in ICSI, a single sperm is selected and injected directly into the cytoplasm of an egg using a fine glass needle.

The ICSI Process

The ICSI procedure typically follows these steps:

Ovarian Stimulation: Similar to IVF, the first step in ICSI involves stimulating the woman's ovaries with hormonal medications to produce multiple eggs. This is closely monitored through blood tests and ultrasounds to ensure optimal follicle development.

Egg Retrieval: Once the eggs are mature, a minor surgical procedure is performed to retrieve them. This is usually done under sedation and involves using a thin needle guided by ultrasound to aspirate the eggs from the ovaries.

Sperm Collection: A sperm sample is collected from the male partner or a sperm donor. In cases of male infertility, where sperm quality may be low, sperm may be obtained through various methods, including surgical retrieval if necessary.

Sperm Selection and Injection: The embryologist examines the sperm sample to identify the healthiest and most motile sperm. A single sperm is then selected and injected directly into an egg using a specialized micro-injection technique. This step is crucial, as the success of ICSI depends on the proper selection and handling of sperm.

Embryo Culture: After fertilization, the embryos are cultured in a controlled laboratory environment. The embryologist monitors their growth and development over the next few days to assess quality.

Embryo Transfer: On day three or five post-fertilization, one or more healthy embryos are selected for transfer into the uterus. This is a relatively simple procedure that involves placing the embryos into the uterine cavity using a thin catheter.

Luteal Phase Support: Following the embryo transfer, hormonal support, typically progesterone, may be provided to help prepare the uterine lining for implantation.

Pregnancy Test: Approximately 10 to 14 days after embryo transfer, a blood test is conducted to check for pregnancy.

Benefits of ICSI

ICSI offers several significant advantages, particularly for couples dealing with male infertility:

Increased Fertilization Rates: By injecting sperm directly into the egg, ICSI bypasses many barriers to fertilization, leading to higher fertilization rates compared to traditional IVF, especially in cases of poor sperm motility or morphology.

Effective for Male Infertility: ICSI is particularly beneficial for couples where male infertility factors are present, such as low sperm count, poor sperm quality, or issues with sperm transport.

Assists with Frozen Sperm: ICSI can be used effectively with frozen sperm samples, making it a viable option for men who may need to bank sperm before undergoing medical treatments or for those with certain health conditions.

Fertility Preservation: For men undergoing treatments that may affect fertility, such as chemotherapy, ICSI provides an opportunity to preserve their fertility and still achieve successful pregnancies later.

Increased Options for Donor Sperm: ICSI allows couples to utilize donor sperm effectively, enhancing their chances of conception while minimizing the impact of male factor infertility.

Limitations and Risks of ICSI

While ICSI is a highly effective procedure, it is not without limitations and potential risks:

Cost: ICSI adds to the overall cost of the IVF process, making it more expensive. This can be a barrier for some couples seeking treatment.

Not a Guarantee of Pregnancy: While ICSI increases the chances of fertilization, it does not guarantee a successful pregnancy. Other factors, such as embryo quality and uterine health, also play significant roles in the outcome.

Possible Genetic Concerns: Some studies have raised concerns about the potential long-term effects of ICSI on offspring, including a slightly increased risk of genetic abnormalities. However, the overall risks remain low, and most children born through ICSI are healthy.

Emotional Stress: The IVF and ICSI processes can be emotionally taxing for couples. The uncertainty of success and the pressures of fertility treatment can lead to anxiety and stress.

Multiple Pregnancies: Although ICSI allows for single embryo transfer, the use of multiple embryos can increase the risk of multiple pregnancies, which can lead to complications for both the mother and babies.

Who Should Consider ICSI?

ICSI is recommended for couples experiencing specific fertility issues, particularly related to male infertility. Some common indications for ICSI include:

Low Sperm Count or Quality: Couples where the male partner has a significantly low sperm count (oligospermia) or poor sperm motility (asthenozoospermia) may benefit from ICSI.

Previous Failed IVF Attempts: Couples who have tried traditional IVF multiple times without success may find that ICSI improves their chances of fertilization.

Surgical Sperm Retrieval: Men who have undergone surgeries that affect sperm transport or production may require ICSI to achieve fertilization.

Frozen Sperm Samples: ICSI is a viable option for couples using frozen sperm, which may have limited motility.

Genetic Disorders: Couples at risk of passing on genetic disorders may benefit from ICSI combined with Preimplantation Genetic Testing (PGT), allowing for the selection of genetically healthy embryos. https://australianconceptkarachi.com/icsi/

Conclusion

Intracytoplasmic Sperm Injection (ICSI) is a groundbreaking advancement in the field of reproductive medicine that has transformed the treatment of male infertility. By allowing for the direct injection of sperm into an egg, ICSI significantly enhances the chances of fertilization, offering hope to couples who may struggle with traditional methods. While the process involves certain risks and costs, the benefits it provides in terms of increased success rates and options for addressing male factor infertility are invaluable. As technology continues to advance and research deepens our understanding of reproductive health, ICSI remains a vital tool for helping couples achieve their dreams of parenthood.

[industryforecastnews]

Neurovascular Devices Market Size To Reach USD 4.53 Billion By 2030

Neurovascular Devices Market Growth & Trends

The global neurovascular devices market size is anticipated to reach USD 4.53 billion by 2030, registering a CAGR of 6.01% from 2023 to 2030, according to a new report by Grand View Research, Inc. The rising prevalence of neurological illnesses such as stroke, brain aneurysm, and cerebral artery stenosis is driving growth of the neurovascular devices market. According to the World Stroke Organization (WSO), in 2022, there will be more than 12.2 million new strokes per year.

One in every four adults above the age of 25 will suffer a stroke throughout their lifetime. In addition, nearly 7.6 million new ischemic strokes occur each year. Around 62.0% of all incident strokes worldwide are ischemic strokes, with more than 1.2 million new subarachnoid hemorrhages occurring each year. As a result, the figures show that there is a significant demand for the neurovascular devices, which is driving neurovascular device market expansion.

The rising prevalence of brain aneurysms in both developed and developing countries is driving the introduction of technologically advanced products to the market. Some significant therapeutic techniques for an intracranial aneurysm include surgical clipping, endovascular coiling, and flow diverters. Market participants are constantly working to introduce technologically advanced products to the market.

For instance, in September 2021, Medtronic plc. announced the CE Mark clearance of its radial artery access portfolio, which comprises the Rist 079 Access Radial Guide Catheter and the Access Rist Radial Selective Catheter. Furthermore, in March 2022, Micro Port Scientific Company announced that its Hyper flex Balloon Catheter has received registration approval from the Japan Pharmaceuticals and Medical Devices Agency (PMDA).

Reduced postoperative discomfort and faster recovery are the factors expanding use of the minimally invasive operations and fueling R&D in this field. Endovascular coiling is a minimally invasive surgery that is frequently suggested by the clinicians for the treatment of cerebral aneurysms. Hydro Coils (MicroVention, Tustin, California, USA) have permitted the treatment of more complex aneurysmal structures with reduced recurrence rates as compared to bare-platinum coils. As a result, increased demand for the minimally invasive procedures is supporting neurovascular device market expansion.

Request a free sample copy or view report summary: https://www.grandviewresearch.com/industry-analysis/neurovascular-devices-market

Neurovascular Devices Market Report Highlights

In 2022, cerebral embolization and aneurysm coiling devices dominated the neurovascular devices market with a market share of 34.79%. As the prevalence of cerebral artery stenosis rises, major players are introducing more technologically advanced products

Based on therapeutic application, stroke segment dominated the market in 2022 with a market share of 57.10% due to the increasing prevalence of stroke, globally. The increasing frequency of strokes around the world has resulted in a significant demand for the management of these cases, necessitating the intensive use of neurovascular devices

Among size, 0.021" held a majority market share of 27.26% in the year 2022. This is due to 0.021” size products are preferred over others owing to superior flow rates and embolic compatibility

Among end use, hospitals held a majority market share of 70.97% in the year 2022. Increasing number of patients being admitted to the hospitals due to the surgeries, therapies, and treatments is expected to favor the neurovascular device market. Thus, subsequent increase in number of patients across the globe, launch of technologically advanced products, and favorable reimbursement policies are leading to a growing demand for the hospital treatments

North America led the market with the maximum revenue share of 26.44% in 2022. Rising demand for the minimally invasive surgeries, and increasing government initiative for improving healthcare infrastructures are among the key factors driving the market growth. In addition, technological advancement and innovation of new noninvasive techniques will create lucrative opportunities for the segment

Regional Insights

North America dominated the neurovascular devices market with the share of 26.44% in 2022 owing to the presence of key manufacturers such as Penumbra, Inc., Stryker Corporation, Johnson & Johnson, and Merit medical systems, Inc. in the region. In February 2023, Phenox Inc. stated that their pRESET Thrombectomy Device has been cleared by the FDA for use in the treatment of acute ischemic stroke. The product pRESET, which has been marketed in Europe for more than  a decade, has now been approved for use in the U.S. Furthermore, rising prevalence of neurological disorders, and increasing demand for the minimally invasive surgical procedures are driving the neurovascular devices market growth in this region.

Neurovascular Devices Market Segmentation

Grand View Research has segmented the global neurovascular devices market based on the device, therapeutic application, size, end use, and regions:

Neurovascular Devices Device Outlook (Revenue USD Million; Volume Unit; 2018 - 2030)

Cerebral Embolization and Aneurysm Coiling Devices

Cerebral Angioplasty and Stenting Systems

Neurothrombectomy Devices

Support Devices

Trans Radial Access Devices

Neurovascular Devices Therapeutic Application Outlook (Revenue USD Million; 2018 - 2030)

Stroke

Cerebral Artery

Cerebral Aneurysm

Others

Neurovascular Devices Size (in Inches) Outlook (Revenue USD Million; 2018 - 2030)

0.027"

0.021"

0.071"

0.017"

0.019"

0.013"

0.058"

0.068"

Others

Neurovascular Devices End Use Outlook (Revenue USD Million; 2018 - 2030)

Hospitals

Specialty Clinics

Others

Neurovascular Devices Regional Outlook (Revenue, USD Million, 2018 - 2030)

North America

Europe

Asia Pacific

Latin America

Middle East and Africa (MEA)

List of Key Players In Neurovascular Devices Market

Medtronic

Johnson and Johnson Services Inc.

Penumbra, Inc.

Micro port Scientific Corporation

Stryker

Microvention Inc. (Terumo Corporation)

Codman Neuro (Integra Life sciences)

Browse Full Report: https://www.grandviewresearch.com/industry-analysis/neurovascular-devices-market